Lactobacillus plantarum LLY-606 supplementation ameliorates hyperuricemia via modulating intestinal homeostasis and relieving inflammation
- 2 June 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 14 (12) , 5663-5677
Abstract
Lactobacillus plantarum LLY-606 supplementation alleviated hyperuricemia and promoted uric acid metabolism. Lactobacillus plantarum LLY-606 supplementation reshaped gut microbiota and downregulated inflammation.Keywords
Funding Information
- National Natural Science Foundation of China (32072214)
This publication has 45 references indexed in Scilit:
- (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1Biomedicine & Pharmacotherapy, 2017
- The Common Gut Microbe Eubacterium hallii also Contributes to Intestinal Propionate FormationFrontiers in Microbiology, 2016
- Intestinal Microbiota Distinguish Gout Patients from Healthy HumansScientific Reports, 2016
- Hyperuricemia-induced inflammasome and kidney diseasesNephrology Dialysis Transplantation, 2015
- The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probioticNature Reviews Gastroenterology & Hepatology, 2014
- The Purine-Utilizing Bacterium Clostridium acidurici 9a: A Genome-Guided Metabolic ReconsiderationPLOS ONE, 2012
- Microbes inside—from diversity to function: the case of AkkermansiaThe ISME Journal, 2012
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- Uric Acid and Chronic Kidney Disease: New Understanding of an Old ProblemSeminars in Nephrology, 2011
- Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacteriumInternational Journal of Systematic and Evolutionary Microbiology, 2004